Nachrichten zur Implantica AG SDR´s Aktie

Implantica announces the payment of share rewards based on the AGM approved share-based incentive program as a directed share issue of own shares of the company without consideration

Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, announces that on 23…

Implantica deepens market penetration in Italy with the addition of the ninth RefluxStop™ Center of Excellence and several lined up to start near-term

Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device…

Implantica submits FDA PMA application Clinical Module 2 for RefluxStop™ for U.S. market approval

Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device…

Implantica announces highly successful 2024 American Foregut Society meeting where RefluxStop® received remarkable pre-launch market feedback

Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, is pleased to report…

Implantica shares a landmark review article on standard of care Nissen Fundoplication anti-reflux surgery – in light of the recently announced excellent RefluxStop[TM] 5-year results

Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device…

Implantica announces another landmark real-world RefluxStop™ study demonstrating excellent outcomes published in a prestigious top-tier journal

Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, announces another key milestone…

Implantica announces excellent RefluxStop™ investigator initiated study results published in Scientific Reports, a Nature journal

Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, announces the independent study…

Implantica announces new health-economics data publication showing RefluxStop™’s superior cost-effectiveness for the Swiss healthcare system

Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, reports the study, “Analysis…

Bulletin from the Annual General Meeting of Implantica AG

Today, May 22, 2024, the annual general meeting (the “AGM”) of Implantica AG (publ) was held in Ruggel, Liechtenstein. The…

Implantica’s RefluxStop™ is now available in seven hospitals in Spain adding two new centers of excellence

Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces that Dra. Beatriz…

Notice of Annual General Meeting of Implantica AG

The depository receipt holders of Implantica AG, reg. no. FL-0002.629.889-3, are hereby invited to attend the annual general meeting to…

Implantica submits U.S. FDA Premarket Approval (PMA) application for RefluxStop® (first module)

Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces the submission of…

Implantica announces live surgery with RefluxStop™ attended by nearly 2’000 surgeons and streamed by up to 100’000 online

Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, announces that the RefluxStop™…

Implanticas RefluxStop[TM], a promising new procedure for chronic acid reflux, offered for the first time in the NHS in UK

Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces that the first…

Invitation to Implantica’s CMD in Stockholm on September 26, 2023

Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, invites investors, analysts, and…

Implantica publishes Interim Report January - June 2023 (Q2)

VADUZ, Liechtenstein, Aug. 24, 2023 /PRNewswire/ -- RefluxStop™ Gaining Significant Traction Across Europe to Battle Acid Reflux Significant events in…

Implantica publishes Interim Report January – June 2023 (Q2)

RefluxStop™ Gaining Significant Traction Across Europe to Battle Acid Reflux Significant events in the second quarter of 2023 · We…

Save the date: Implantica Capital Markets Day 2023

Implantica AG (publ) will arrange a Capital Markets Day (CMD) for investors, analysts and media on Tuesday, 26 September 2023,…

AKTIONÄR-Tipp Implantica gibt wieder Gas: Termin voraus

Der Medizintechnik-Wert steigt am Freitag gegen den Markt an der Stockholmer Börse um knackige acht Prozent. In der kommenden Woche…

Implantica presents the second quarter 2023 on August 24 at 15:00 CET

VADUZ, Liechtenstein, Aug. 18, 2023 /PRNewswire/ -- Implantica AG (publ) invites investors to a presentation of the second quarter 2023…

Implantica presents the second quarter 2023 on August 24 at 15:00 CET

Implantica AG (publ) invites investors to a presentation of the second quarter 2023 at 15:00 CET on August 24. The…

AKTIONÄR-Tipp Implantica: Mega-Potenzial in den USA – Aktie klettert weiter

Die Aktie des Medizintechnik-Spezialisten Implantica hat sich in der vergangenen Woche mit einem satten Kursplus zurückgemeldet (...…

AKTIONÄR-Tipp Implantica: Kurssprung – das ist der Grund

In Ausgabe 31/2023 hat DER AKTIONÄR den schwedischen Aktienmarkt etwas genauer unter die Lupe genommen und mit...…

Implantica Further Expands its Commercial Footprint in Italy

Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, announces that the first…

Implantica reports that two independent surgeons presented their RefluxStop™ patient data at the 2023 Annual Swiss College of Surgeons Congress (SCS)

Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, announces that two independent…

Implantica Announces Completion of First RefluxStop™ procedures by the President of the European Foregut Society

Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, announces today that the…

Bulletin from the Annual General Meeting of Implantica AG

VADUZ, Liechtenstein, May 26, 2023 /PRNewswire/ -- Today, May 25, 2023, the annual general meeting (the "AGM") of Implantica AG…

Bulletin from the Annual General Meeting of Implantica AG

Today, May 25, 2023, the annual general meeting (the “AGM”) of Implantica AG (publ) was held in Ruggel, Liechtenstein. The…

Implantica announces that RefluxStop™ results were presented at the DDW Conference in Chicago

Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, announces that Dr. med.…

Implantica publishes Interim Report January - March 2023 (Q1)

RefluxStop™ - Designed for a Revolution in the Care of Acid Reflux VADUZ, Liechtenstein, May 12, 2023 /PRNewswire/ -- Significant…

Implantica publishes Interim Report January – March 2023 (Q1)

RefluxStop™ - Designed for a Revolution in the Care of Acid Reflux Significant events in the first quarter of 2023 …

Implantica recognized among the “50 Admired Companies to Watch in 2023”

Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, announces today that CIO…

Implantica presents the first quarter 2023 on May 12 at 15:00 CET

VADUZ, Liechtenstein, May 5, 2023 /PRNewswire/ -- Implantica AG (publ) invites investors to a presentation of the first quarter 2023…

Implantica presents the first quarter 2023 on May 12 at 15:00 CET

Implantica AG (publ) invites investors to a presentation of the first quarter 2023 at 15:00 CET on May 12. The…

Notice of Annual General Meeting of Implantica AG

VADUZ, Liechtenstein, May 4, 2023 /PRNewswire/ -- The depository receipt holders of Implantica AG, reg. no. FL-0002.629.889-3, are hereby invited…

Notice of Annual General Meeting of Implantica AG

The depository receipt holders of Implantica AG, reg. no. FL-0002.629.889-3, are hereby invited to attend the annual general meeting to…

Implantica Announces 100[th] RefluxStop™ Procedure Completed in a Single Center of Excellence in Germany

Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, congratulates the hospital Klinikum…

Implantica publishes Annual Report 2022

VADUZ, Liechtenstein, April 20, 2023 /PRNewswire/ -- Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology…

Implantica publishes Annual Report 2022

Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual…

Repurchase of Implantica AG own shares during week 15, 2023

Implantica AG (publ) has during week 15 completed repurchases of own shares (Swedish Depository Receipts representing class A shares in…

Repurchase of Implantica AG own shares until April 6, 2023

Implantica AG (publ) has from 29 March 2023 until 6 April 2023 completed repurchases of own shares (Swedish Depository Receipts…

Implantica Announces Another Major European Center of Excellence in Italy starting with the RefluxStop™ procedure

Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, today announces that the…

Implantica announces Dr. med. Yves Borbély Presented his 3-year Data on RefluxStop[TM] []at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES)

Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, announces that Dr. Borbély…

dpa-AFX ProFeed